Leadership Overview
Daewoong Pharmaceutical has 4 executives leading key functions including strategy, operations, and market expansion.
Driven by a commitment to global health, Daewoong Pharmaceutical develops, manufactures, and commercializes pharmaceuticals, providing total healthcare solutions worldwide through robust R&D and cGMP-qualified facilities.
Driven by a commitment to global health, Daewoong Pharmaceutical develops, manufactures, and commercializes pharmaceuticals, providing total healthcare solutions worldwide through robust R&D and cGMP-qualified facilities.
Leadership Roles at Daewoong Pharmaceutical
Minsuk Lee - Chief Executive Officer
Minsuk Lee, the Chief Executive Officer at Daewoong Pharmaceutical, directs the company's overarching strategy and global market positioning. Overseeing all major business units, Lee ensures alignment with the company's mission to become a leading global healthcare provider. This leadership role involves driving innovation in pharmaceutical development and commercialization, leveraging Daewoong's strong in-house R&D capabilities and cGMP-qualified manufacturing facilities. Minsuk Lee focuses on expanding international operations, establishing new branch offices and research centers across Asia and the United States to enhance global reach. The Chief Executive Officer's strategic decisions directly impact the company's ability to deliver comprehensive healthcare solutions to customers worldwide, fostering growth and solidifying Daewoong's presence in competitive international markets. Lee's executive oversight guarantees the continuous pursuit of advanced therapeutic solutions and operational excellence.
Hyun Howoong - Chief Executive Officer & President
Hyun Howoong, the Chief Executive Officer & President at Daewoong Pharmaceutical, spearheads the company's strategic direction and operational execution. Howoong manages the development, manufacturing, and commercialization of pharmaceuticals, ensuring adherence to stringent quality standards and global regulatory requirements. This executive position involves guiding the expansion of Daewoong's international footprint, including the establishment and management of research centers and branch offices in key global markets. Hyun Howoong drives initiatives to enhance the company's total healthcare solutions offering, utilizing its robust R&D infrastructure and cGMP-certified manufacturing capabilities. The Chief Executive Officer & President's leadership ensures that Daewoong Pharmaceutical effectively serves both domestic and international customers, reinforcing its commitment to becoming a premier global healthcare entity. Howoong's focus remains on optimizing global operations and fostering innovation.
Shawn Park - Chief Executive Officer & President
Shawn Park, the Chief Executive Officer & President at Daewoong Pharmaceutical, commands the company's strategic vision and operational framework. Park directs the comprehensive lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global commercialization. This critical role involves overseeing the expansion of Daewoong's international presence, including the strategic placement of research facilities and operational branches across Asia and the United States. Shawn Park champions the company's objective to deliver complete healthcare solutions, capitalizing on its advanced R&D and cGMP-compliant manufacturing operations. The Chief Executive Officer & President's leadership ensures Daewoong Pharmaceutical effectively meets the needs of its global customer base, solidifying its status as a significant player in the international healthcare sector. Park's executive mandate prioritizes market penetration and product innovation.
Namho Kwak - President
Namho Kwak, the President at Daewoong Pharmaceutical, oversees critical aspects of the company's operational and strategic initiatives. Kwak's responsibilities encompass driving the development and commercialization of pharmaceutical products, ensuring that Daewoong's offerings meet the highest standards of quality and efficacy. This leadership position involves managing key functions that support the company's ambition to be a global healthcare leader, leveraging its established R&D strengths and cGMP manufacturing capabilities. Namho Kwak plays a vital role in expanding Daewoong's international market reach, coordinating efforts to establish and optimize operations in various global regions. The President's focus is on enhancing the company's comprehensive healthcare solutions and ensuring seamless integration of its domestic and international business activities. Kwak's executive guidance supports sustained growth and market leadership.
Explore Leadership Teams in Manufacturing
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.
Company Leadership
SM
KB
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
AC
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
MA
Avara Pharmaceutical Services is a manufacturing organization. It offers aseptic liquid filling, sterile pharmaceutical, oral solid dose, packaging solutions and sterile injectables. The company was founded in 2015 and is located in Norman, Oklahoma.
Company Leadership AA
RM
RR
Frequently Asked Questions Regarding Daewoong Pharmaceutical Top Executives and Leadership Team
